We are live on ! Find out more
SYRA

Syra Health Corp. Class A Common Stock
SYRA

Delisted

SYRA was delisted on the 17th of April, 2025.

Back to rankings

9 hedge funds and large institutions have $125K invested in Syra Health Corp. Class A Common Stock in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

82% more capital invested

Capital invested by funds: $69.1K → $125K (+$56.3K)

50% more funds holding

Funds holding: 6 → 9 (+3)

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$55.2K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$41.3K
3
TSS
Two Sigma Securities
New York
+$17K
4
DLCIG
D.L. Carlson Investment Group
New Hampshire
+$16.1K
5
TRCT
Tower Research Capital (TRC)
New York
+$6.75K

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$56K
2
TC
Torno Capital
Massachusetts
-$11.2K
3
Bank of America
Bank of America
North Carolina
-$2

SYRA Hedge Fund Activity: Q1 2024 in Review

9 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q1 2024, worth a combined $125K — up 82% from $69.1K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new SYRA positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $55.2K. The largest seller was Walleye Capital, exiting entirely with an estimated $56K sold.

  • 9 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q1 2024, up from 6 in Q4 2023.
  • Funds reported $125K of Syra Health Corp. Class A Common Stock stock for Q1 2024, up 82% quarter-over-quarter.
  • 6 funds opened new Syra Health Corp. Class A Common Stock positions in Q1 2024 and 3 closed out, a net change of +3 holders.
  • The largest Syra Health Corp. Class A Common Stock buyer in Q1 2024 was Vanguard Group, an estimated $55.2K added.
  • The largest Syra Health Corp. Class A Common Stock seller in Q1 2024 was Walleye Capital, an estimated $56K sold.

Based on aggregated 13F filings for Q1 2024.